News
Press Releases

Tuesday, August 14, 2012

Stemedica International Receives Licenses from Swissmedic for Import and Export of its Stemedyne™ Stem Cell Line

Stemedica International, SA (Epalinges, Switzerland), a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (“Stemedica”), a leader in adult stem cell research and manufacturing, announced today that it has been granted a series of licenses by Swissmedic (the Swiss equivalent of the United States Food and Drug Administration). These licenses specifically authorize the Company to… https://caberfaepeaks.com/school/do-my-assignment-pay/27/ professional scholarship essay editor service usa mathematics essay writer websites family fun homework help enter site see https://jesuswired.com/writing/buy-a-business-plan/12/ bailey house – case study house follow url writing a review article here media coordinator resume samples cheapest cialis 20mg go site custom report writing spongebob essay font speech organization where do i go if i have no insurance and need cialis louisiana purchase essay questions do annotated bibliography have to be in alphabetical order enter https://secondhelpingsatlanta.org/consequences-of-stealing-essay-3655/ http://www.naymz.com/wmu-creative-writing-major/ https://erc.cals.wisc.edu/wp-content/blogs.dir/25/store.php?usp=tetracycline-500mg-no-prescription cheap nizagara art history paper thesis Buying Generic Cialis custom my essay meister see purdue thesis search Read Entire Article

Thursday, May 24, 2012

Stemedica International and Academic Partner Awarded Swiss Alzeheimer’s and Stem Cell Research Grant.

Stemedica International, Epalinges, Switzerland, a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (San Diego, CA) announced today that it was awarded a grant by the Swiss Commission for Technology and Innovation along with its academic partner, The École Polytechnique Fédérale de Lausanne (EPFL). The 584,522 CHF (approx. 620,000 USD) grant is focused on the…
Read Entire Article
« Newer Entries